West Pharmaceutical Services Debt to Equity Ratio 2006-2018 | WST

Current and historical debt to equity ratio values for West Pharmaceutical Services (WST) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. West Pharmaceutical Services debt/equity for the three months ending September 30, 2018 was 0.15.
West Pharmaceutical Services Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $0.20B $1.35B 0.15
2018-06-30 $0.20B $1.28B 0.15
2018-03-31 $0.20B $1.31B 0.15
2017-12-31 $0.20B $1.28B 0.15
2017-09-30 $0.20B $1.32B 0.15
2017-06-30 $0.20B $1.24B 0.16
2017-03-31 $0.19B $1.17B 0.17
2016-12-31 $0.23B $1.12B 0.20
2016-09-30 $0.23B $1.14B 0.20
2016-06-30 $0.23B $1.11B 0.21
2016-03-31 $0.23B $1.07B 0.21
2015-12-31 $0.23B $1.02B 0.22
2015-09-30 $0.23B $1.00B 0.23
2015-06-30 $0.23B $0.99B 0.23
2015-03-31 $0.23B $0.94B 0.25
2014-12-31 $0.31B $0.96B 0.32
2014-09-30 $0.32B $0.97B 0.33
2014-06-30 $0.36B $0.97B 0.37
2014-03-31 $0.39B $0.94B 0.42
2013-12-31 $0.37B $0.91B 0.41
2013-09-30 $0.38B $0.84B 0.46
2013-06-30 $0.40B $0.78B 0.50
2013-03-31 $0.43B $0.75B 0.57
2012-12-31 $0.38B $0.73B 0.52
2012-09-30 $0.36B $0.72B 0.51
2012-06-30 $0.30B $0.68B 0.44
2012-03-31 $0.30B $0.70B 0.42
2011-12-31 $0.30B $0.66B 0.46
2011-09-30 $0.32B $0.69B 0.47
2011-06-30 $0.37B $0.70B 0.53
2011-03-31 $0.37B $0.66B 0.55
2010-12-31 $0.36B $0.63B 0.57
2010-09-30 $0.37B $0.63B 0.58
2010-06-30 $0.36B $0.57B 0.63
2010-03-31 $0.35B $0.58B 0.60
2009-12-31 $0.38B $0.58B 0.66
2009-09-30 $0.39B $0.57B 0.70
2009-06-30 $0.39B $0.53B 0.73
2009-03-31 $0.38B $0.49B 0.79
2008-12-31 $0.38B $0.49B 0.78
2008-09-30 $0.38B $0.53B 0.72
2008-06-30 $0.40B $0.55B 0.73
2008-03-31 $0.42B $0.51B 0.82
2007-12-31 $0.40B $0.49B 0.81
2007-09-30 $0.39B $0.48B 0.82
2007-06-30 $0.38B $0.49B 0.78
2007-03-31 $0.38B $0.46B 0.82
2006-12-31 $0.24B $0.42B 0.57
2006-09-30 $0.24B $0.40B 0.60
2006-06-30 $0.26B $0.39B 0.67
2006-03-31 $0.27B $0.36B 0.75
2005-12-31 $0.28B $0.34B 0.83
2005-09-30 $0.26B $0.33B 0.80
2005-06-30 $0.28B $0.32B 0.88
2005-03-31 $0.15B $0.31B 0.50
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $8.159B $1.599B
West Pharmaceutical Services, Inc. is a global drug delivery technology company that applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines and consumer healthcare products. West is the world's premiere provider of standard-setting systems and device components for parenterally administered medicines and an emerging leader in the development of advanced formulation technologies for the transmucosal delivery of drugs. West contract manufacturing harnesses a powerful combination of innovation, technology, infrastructure and expertise to serve the pharmaceutical, medical and consumer industries. Along with more than 50 years of experience, they bring customers quality, safety and reliability in injection molding, contract assembly and finished packaging.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $65.839B 22.43
McKesson (MCK) United States $24.205B 9.25
AmerisourceBergen (ABC) United States $19.202B 13.70
Align Technology (ALGN) United States $18.029B 46.00
Laboratory Of America Holdings (LH) United States $16.578B 15.01
Cardinal Health (CAH) United States $16.524B 11.09
Henry Schein (HSIC) United States $13.120B 21.57
Cooper (COO) United States $13.023B 23.45
DENTSPLY SIRONA (XRAY) United States $8.279B 16.53
Merit Medical Systems (MMSI) United States $3.360B 39.79
Patterson (PDCO) United States $2.427B 17.06
CONMED (CNMD) United States $1.929B 32.05
STAAR Surgical (STAA) United States $1.784B 183.77
Atrion (ATRI) United States $1.343B 38.40
Antares Pharma (ATRS) United States $0.532B 0.00
Invacare (IVC) United States $0.189B 0.00
Lifevantage (LFVN) United States $0.161B 22.84
Endologix (ELGX) United States $0.106B 0.00
Pro-Dex (PDEX) United States $0.061B 27.17
Aceto (ACET) United States $0.055B 0.00
Biolase (BIOL) United States $0.027B 0.00